Global Artificial Pancreas Devices System Market 2016-2020

SKU ID : TNV-IRTNTR11134

Publishing Date : 14-Dec-2016

No. of pages : 85

PRICE
2500
4000


  • About Artificial Pancreas Devices System

    Artificial organs are human-made bioartificial devices, which are implanted or integrated into individuals to replace or support natural organs. These include artificial heart, kidney, pancreas, and cochlear implants. Biocompatible materials such as polymers (polyurethane, polysulfone, and porous polypropylene), biologics, ceramics, and metals are used to develop artificial organs. These organs are incorporated with different technologies like sensors, biomaterials, and innovative delivery systems. Artificial organs perform the function of the natural organ and help the patient to live a quality life. In few cases, artificial organs are capable of eliminating the need for organ transplantation altogether.

    Technavio’s analysts forecast the global artificial pancreas devices system market to grow at a CAGR of 7.40% during the period 2016-2020.

    Covered in this report
    The report covers the present scenario and the growth prospects of the global artificial pancreas devices system market for 2016-2020. To calculate the market size, the report considers the revenue generated from sales of the different products.

    The market is divided into the following segments based on geography:
    • Americas
    • APAC
    • EMEA

    Technavio's report, Global Artificial Pancreas Devices System Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

    Key vendors
    • Medtronic
    • Johnson & Johnson
    • Insulet
    • Tandem Diabetes Care
    • Roche

    Other prominent vendors
    • Beta Bionics
    • Bigfoot Biomedical
    • Cellnovo
    • Dexcom
    • Dose Safety
    • DreaMed Diabetes
    • Inreda Diabetic
    • Type Zero Technologies

    Market driver
    • Growing technological integration fueling the market growth.
    • For a full, detailed list, view our report

    Market challenge
    • Lack of smart control algorithms affecting the adoption rate of existing APDS.
    • For a full, detailed list, view our report

    Market trend
    • Growing demand for remote monitoring application.
    • For a full, detailed list, view our report

    Key questions answered in this report
    • What will the market size be in 2020 and what will the growth rate be?
    • What are the key market trends?
    • What is driving this market?
    • What are the challenges to market growth?
    • Who are the key vendors in this market space?
    • What are the market opportunities and threats faced by the key vendors?
    • What are the strengths and weaknesses of the key vendors?

    You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.




    Detailed TOC of Global Artificial Pancreas Devices System Market 2016-2020

    Table of Contents
    PART 01: Executive summary
    • Highlights
    PART 02: Scope of the report
    • Market overview
    • Assumptions
    • Top-vendor offerings
    PART 03: Market research methodology
    • Research methodology
    • Economic indicators
    PART 04: Introduction
    • Key market highlights
    • A glance at parent market: Artificial organs
    PART 05: An overview of pancreas and diabetes
    • Pancreas
    • Diabetes
    • Insulin overview
    PART 06: Need for better systems in the management of diabetes
    PART 07: Artificial pancreas device system
    • Technology landscape
    PART 08: Initiatives for the development of APDS
    • Juvenile Diabetes Research Foundation (JDRF) initiative — 2006
    • European Commission’s AP@home project — 2010
    • Centre for bio-inspired technology — Bionic pancreas
    • Harvard University — 2014
    PART 09: FDA’s role in fostering the development of APDS
    • Rapid response to preliminary study plans
    • Interactive review of investigational device exemption study plans
    • Guidance and standards for researchers and industry
    PART 10: Reimbursement scenario
    • Australia
    • Germany
    • UK
    • US
    PART 11: Key clinical trials
    PART 12: Market landscape
    • Market overview
    • Five forces analysis
    PART 13: Market segmentation by categories
    • TSDS
    • NTSDS
    • CTRS
    • CTTS
    PART 14: Geographical segmentation
    • APDS market in Americas
    • APDS market in EMEA
    • APDS market in APAC
    PART 15: Market drivers
    • Growing technological integration fuelling the market growth
    • Increasing initiatives of research organizations fostering innovation in the market
    • Increasing prevalence of diabetes fuelling the need for effective devices
    PART 16: Impact of drivers
    PART 17: Market challenges
    • Lack of smart control algorithms affecting the adoption rate of existing APDS
    • Low penetration rates affecting the market growth
    • Lab-grown pancreatic cell transplant as a potential treatment alternative hindering the growth prospects
    PART 18: Impact of drivers and challenges
    PART 19: Market trends
    • Increasing focus on closed loop systems
    • Growing demand for remote monitoring applications
    • Focus of new entrants on the development of novel APDS
    PART 20: Vendor landscape
    • Competitive scenario
    PART 21: Key vendor analysis
    • Medtronic
    • Johnson & Johnson
    • Insulet
    • Tandem Diabetes Care
    • Roche
    • Other prominent vendors
    PART 22: Appendix
    • List of abbreviations
    PART 23: Explore Technavio
    List of Exhibits
    Exhibit 01: Product offerings
    Exhibit 02: Key segments in artificial organ market
    Exhibit 03: Diagnosis of diabetes by blood sugar test
    Exhibit 04: Diagnosis of diabetes by glycated hemoglobin test
    Exhibit 05: Treatment algorithm for type 2 diabetes
    Exhibit 06: Factors that fuelled the need for APDS
    Exhibit 07: Technology involved in the functioning of APDS
    Exhibit 08: Barriers in CGM
    Exhibit 09: Barriers in hormonal pumps
    Exhibit 10: Key findings of researchers related to algorithms till date
    Exhibit 11: Key clinical trials
    Exhibit 12: Global APDS market snapshot
    Exhibit 13: Development path of APDS
    Exhibit 14: Global APDS market 2015-2020 ($ millions)
    Exhibit 15: Key factors driving the demand for closed loop systems
    Exhibit 16: Scenario analysis of global APDS market
    Exhibit 17: Five forces analysis
    Exhibit 18: Pipeline products
    Exhibit 19: Key pipeline products
    Exhibit 20: Scenario analysis of key segments in global APDS market
    Exhibit 21: Segmentation of global APDS market based on geography 2015 and 2020
    Exhibit 22: APDS market revenue by geography 2015-2020 ($ millions)
    Exhibit 23: Market scenario in Americas
    Exhibit 24: APDS market in the Americas ($ millions)
    Exhibit 25: Market scenario in EMEA
    Exhibit 26: APDS market in EMEA ($ millions)
    Exhibit 27: Market scenario in EMEA
    Exhibit 28: APDS market in APAC ($ millions)
    Exhibit 29: Key technological integrations
    Exhibit 30: Key initiatives of research organizations
    Exhibit 31: Incidence and prevalence for diabetes in the US
    Exhibit 32: Traditional systems vs APDS
    Exhibit 33: Impact of drivers
    Exhibit 34: Forcefield analysis of drivers and challenges
    Exhibit 35: Impact of drivers and challenges
    Exhibit 36: Key trends in the development of closed loop systems
    Exhibit 37: Key products under development for remote monitoring applications
    Exhibit 38: New entrants and their expected product launches
    Exhibit 39: Competitive structure analysis of global APDS market 2015
    Exhibit 40: Competitive analysis of global APDS market
    Exhibit 41: Market share analysis 2015
    Exhibit 42: Market penetration of various APDS manufacturers in global (2015)
    Exhibit 43: Timeline chart representing the development of APDS
    Exhibit 44: Strategic success factors of companies in global APDS market
    Exhibit 45: Key highlights
    Exhibit 46: Strength assessment
    Exhibit 47: Strategy assessment
    Exhibit 48: Opportunity assessment
    Exhibit 49: Key highlights
    Exhibit 50: Strength assessment
    Exhibit 51: Strategy assessment
    Exhibit 52: Opportunity assessment
    Exhibit 53: Key highlights
    Exhibit 54: Strength assessment
    Exhibit 55: Strategy assessment
    Exhibit 56: Opportunity assessment
    Exhibit 57: Key highlights
    Exhibit 58: Strength assessment
    Exhibit 59: Strategy assessment
    Exhibit 60: Opportunity assessment
    Exhibit 61: Key highlights
    Exhibit 62: Strength assessment
    Exhibit 63: Strategy assessment
    Exhibit 64: Opportunity assessment

    Keyplayers in Global Artificial Pancreas Devices System Market 2016-2020

    Medtronic, Johnson & Johnson, Insulet, Tandem Diabetes Care, Roche, Beta Bionics, Bigfoot Biomedical, Cellnovo, Dexcom, Dose Safety, DreaMed Diabetes, Inreda Diabetic, Type Zero Technologies.

    Related REPORTS